Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

10 projects found matching your search criteria :

  1. Flavonoid phytoprogestins as novel non-steroidal progesterone receptor modulators in a nutraceutical approach to endomet...

    Call: PRELUDIUM 24 , Panel: NZ9

    Principal investigator: Agata Gołąbek-Grenda

    Uniwersytet Przyrodniczy w Poznaniu

  2. Mimicking the endometrium in three-dimensional cell culture model to study hypoxia-induced endometrial changes and embry...

    Call: OPUS 28 , Panel: NZ9

    Principal investigator: prof. Agnieszka Wacławik

    Instytut Rozrodu Zwierząt i Badań Żywności PAN

  3. Application of spherical 3D printing to create a multi-layered hydrogel skin model

    Call: OPUS 27 , Panel: ST8

    Principal investigator: dr Szymon Mania

    Politechnika Gdańska

  4. Identification of novel disease modifiers in Huntington's disease: neuro-glia interactions in the patient-derived multid...

    Call: SONATA BIS 11 , Panel: NZ3

    Principal investigator: dr Agnieszka Marta Krzyżosiak

    Sieć Badawcza ŁUKASIEWICZ - PORT Polski Ośrodek Rozwoju Technologii

  5. A novel approach based on the optimized multidrug combination for glioblastoma treatment.

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: prof. Małgorzata Kucińska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  6. The effect of methylated resveratrol analogue 3,4,4',5-tetramethoxystilbene (DMU-212) on secretion profile and different...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Małgorzata Józkowiak

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  7. Novel model for in vitro analyzing breast cancer, colorectal cancer and prostate cancer cells.

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Piotr Rieske

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  8. Effectiveness of anticancer activity of DMU-214 (3'-hydroxy-3,4,5,4'-tetrametoxystilbene) in personalized treatment for ...

    Call: SONATA 12 , Panel: NZ7

    Principal investigator: dr hab. Hanna Helena Piotrowska-Kempisty

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  9. Bronchial fibroblast to myofibroblast transition - the role of differential activation of TGF-beta/Smad signalling pathw...

    Call: OPUS 9 , Panel: NZ3

    Principal investigator: dr hab. Marta Teresa Michalik

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  10. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Zofia Felicja Bielecka

    Wojskowy Instytut Medyczny